Your browser doesn't support javascript.
loading
Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy.
Support Care Cancer ; 5(4): 289-98, 1997 Jul.
Article in En | MEDLINE | ID: mdl-9257425
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Granulocyte Colony-Stimulating Factor / Granulocyte-Macrophage Colony-Stimulating Factor / Neoplasms / Neutropenia Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 1997 Document type: Article Affiliation country: United States Country of publication: Germany
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Granulocyte Colony-Stimulating Factor / Granulocyte-Macrophage Colony-Stimulating Factor / Neoplasms / Neutropenia Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 1997 Document type: Article Affiliation country: United States Country of publication: Germany